Management of diabetes mellitus in hospitalized patients: Efficiency and effectiveness of sliding-scale insulin therapy

Pharmacotherapy

Volumn 26, Issue 10, 2006, Pages 1421-1432

  Golightly, Larry K ^a   Jones, Michael A ^a   Hamamura, Dana H ^a   Stolpman, Nancy M ^a   McDermott, Michael T ^a  

^a UNIVERSITY OF COLORADO HOSPITAL   (United States)

Author keywords

Diabetes mellitus; Inpatient management; Insulin

Indexed keywords

ANTIDIABETIC AGENT; ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; CORTICOSTEROID; DIURETIC AGENT; GASTROINTESTINAL AGENT; GLIBENCLAMIDE; GLIPIZIDE; GLUCOSE; IMMUNOLOGIC AGENT; INSULIN; INSULIN LISPRO; PSYCHOTROPIC AGENT; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE; VASOACTIVE AGENT;

ADULT; ARTICLE; DIABETES MELLITUS; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL DOCUMENTATION; PATIENT MONITORING; PRESCRIPTION; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; HOSPITALIZATION; HUMANS; HYPOGLYCEMIA; INPATIENTS; INSULIN; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 33749467354     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.26.10.1421     Document Type: Article

References (54)

1. Fonseca V, Bakris GL, Benjamin EA, et al, on behalf of the American Diabetes Association Professional Practice Committee. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006;29(suppl 1):43-8.
2. McCowan KC, Malhotra A, Bistrian BR. Endocrine and metabolic dysfunction syndromes in the critically ill: stress-induced hyperglycemia. Crit Care Clin 2001;17:107-24.
3. Van den Berghe G, Wouters P, Weckers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-67.
4. Thomas MC, Mathew TH, Russ GR, Rao MM, Moran J. Early peri-operative glycaemic control and allograft rejection in patients with diabetes mellitus: a pilot study. Transplantation 2001;72:1321-4.
5. Thomas MC, Mathew TH, Russ GR. Glycaemic control and graft loss following renal transplantation. Nephrol Dial Transplant 2001;16:1978-82.
6. Malmberg K, Rydén L, Hamsten A, Herlitz J, Waldenstrom A, Wedel H. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. Eur Heart J 1996;17:1337-44.
7. Malmberg K. Prospective randomised study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 1997;314:1512-15.
8. Furnary AP, Gao G, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary bypass grafting. J Thorac Cardiovasc Surg 2003;125:1007-21.
9. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of infection in diabetics after open heart operations. Ann Thorac Surg 1997;63:356-61.
10. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999;67:352-62.
11. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of inhospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002;87;978-82.
12. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, Smith H. Infection and diabetes: the case for glucose control. Am J Med 1982;72:439-50.
13. Bagdade JD, Root RK, Bulger RJ. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 1974;23:9-15.
14. McAlister FA, Majumdar SR, Blitz S, Rowe BG, Romney J, Marrie TJ. The relation between hyperglycemia and outcomes in 2471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care 2005;28:810-15.
15. Pomposelli JJ, Baxter JK, Babineau TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. J Parenter Enter Nutr 1998;22:77-81.
16. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.
17. Malmberg K, Yusuf S, Gerstein HC, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: result of the OASIS (organization to assess strategies for ischemic syndromes) registry. Circulation 2000;102:1014-19.
18. Lewis EF, Moye LA, Rouleau JI, et al. Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE (cholesterol and recurrent events) trial. J Am Coll Cardiol 2003;42:1446-53.
19. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002;40:1748-54.
20. Fish LS, Weaver TW, Moore AL, Steel LG. Value of postoperative blood glucose in predicting complications and length of stay after coronary artery bypass grafting. Am J Cardiol 2003;92:74-6.
21. Golden SH, Kao WHL, Peart-Vigilance C, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 1999;22:1408-14.
22. McAlister FA, Amad H, Man J, Tandon P, Bistritz L. Diabetes and coronary artery bypass surgery: an explanation of perioperative glycemic control and outcomes. Diabetes Care 2003;26:1518-24.
23. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001;32:2426-32.
24. Baird TA, Parsons MW, Phanh T, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003;34:2208-14.
25. Klein S. Nutrition support. In: Green GB, Harris IS, Lin GA, Moylan KC, eds. The Washington manual of medical therapeutics, 31st ed. Philadelphia: Lippincott Williams & Wilkins, 2004:23-38.
26. Campbell RK, White JR Jr, Shapiro K, et al, on behalf of the American Society of Health-System Pharmacists Commission on Therapeutics. ASHP position statement on strict glycemic control in patients with diabetes. Am J Health Syst Pharm 2003;60:2357-62.
27. Powers AC. Diabetes mellitus. In: Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL, eds. Harrison's principles of internal medicine, 16th ed. New York: McGraw-Hill, 2005:2152-80.
28. Oki JC, Isley WL. Diabetes mellitus. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey ML, eds. Pharmacotherapy: a pathophysiologic approach, 5th ed. New York: McGraw-Hill, 2002:1335-58.
29. Clement S, Braithwaite SS, Magee MF, et al, on behalf of the American Diabetes Association's Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004;27:553-91.
30. Fonseca V, Bakris GL, Benjamin EA, et al, on behalf of the American Diabetes Association Professional Practice Committee. Standards of medical care in diabetes. Diabetes Care 2006;29(suppl 1):S4-42.
31. McDonough KA, DeWitt DE. Inpatient management of diabetes. Prim Care 2003;30:557-67.
32. Abourizk NN, Vora CK, Verma PK. Inpatient diabetology: the new frontier. J Gen Intern Med 2004;19:466-71.
33. Bloomgarden ZT. Inpatient diabetes control: approaches to treatment. Diabetes Care 2004;27:2272-7.
34. Trence DL, Kelly JL, Hirsch IB. The rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for change. J Clin Endocrinol Metab 2003;88:2430-7.
35. Koproski J, Pretto Z, Poretsky L. Effects of an intervention by a diabetes team in hospitalized patients with diabetes. Diabetes Care 1997;20:1553-5.
36. Baldwin D, McNutt R, Villanueva G, Bhatnagar S. Eliminating inpatient sliding-scale insulin: a reeducation project with medical house staff. Diabetes Care 2005;28:1008-11.
37. Garrasquillo I, Zonszein J. Proactive insulin therapy (PIT) in hospitalized patients with type 2 diabetes (T2DM), an alternative to regular insulin sliding scale coverage [abstr]. Diabetes 2003;52(suppl 1):258.
38. Donihi AC, Dinardo M, Devita MA, Korytkowski MT. Development and implementation of a standardized inpatient protocol for sliding-scale insulin [abstrl. Diabetes 2004;53(suppl 2):123.
39. Inzucchi SE. Diabetes facts and guidelines 2005. New Haven, CT: Yale Diabetes Center/Takeda Pharmaceuticals, 2004.
40. Davis SN. Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's the pharmacological basis of therapeutics, 11th ed. New York: McGraw-Hill; 2006:1613-45.
41. American Diabetes Association. Bedside blood glucose monitoring in hospitals [position statement]. Diabetes Care 2004;27(suppl 1):S104.
42. Sawin CT. Action without benefit: the sliding scale of insulin use [comment]. Arch Intern Med 1997;157:489.
43. Steinke J. Current concepts: management of diabetes mellitus and surgery. N Engl J Med 1970;282:1472-4.
44. Adler E, Paauw D. Medical myths involving diabetes. Prim Care 2003;30:607-18.
45. Gill G, MacFarlane I. Are sliding-scale insulin regimens a recipe for diabetic instability [letter]? Lancet 1997;349:1555.
46. Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med 1997;157:545-52.
47. Dickerson LM, Ye X, Sack JL, Hueston WJ. Glycemic control in medical inpatients with type 2 diabetes mellitus receiving sliding-scale insulin regimens versus routine diabetes medications: a multicenter randomized controlled trial. Ann Fam Med 2003;1:29-35.
48. Gearhart JG, Duncan JL, Replogic WH, Forbes RC, Walley EJ. Efficacy of sliding-scale insulin therapy: a comparison with prospective regimens. Fam Pract Res J 1994;14:313-22.
49. Arnold P, Braithwaite SS, Hall CE, et al. Patient safety net: sharing stories to improve safety. Safe use of insulin. Oakbrook, IL: University HealthSystem Consortium; 2005. Available from http://www.uhc.edu/WEB/MIT/PSN/ Foundln Net/SafeUseof Insulin.pdf. Accessed March 29, 2005.
50. Mathis AS, Liu MT. Corticosteroids as important causes of hyperglycemia. Am J Health Syst Pharm 2005;62:1976-9.
51. Dailey AD, Lutomski DM. Effectiveness of sliding-scale insulin in inpatients with diabetes mellitus. J Pharm Technol 2003;19:203-8.
52. Smith WD, Winterstein AG, Johns T, Rosenberg E, Sauer BC. Causes of hyperglycemia and hypoglycemia in adult patients. Am J Health Syst Pharm 2005;62:714-19.
53. Rafoth RJ. Standardizing sliding scale insulin orders. Am J Med Qual 2002;17:175-8.
54. Rozich JD, Howard RJ, Justeson JM, Macken PD, Lindsay ME, Resar RK. Standardization as a mechanism to improve safety in health care. Jt Comm J Qual Saf 2004;30:5-14.